DE69718338T2 - 3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate - Google Patents

3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate

Info

Publication number
DE69718338T2
DE69718338T2 DE69718338T DE69718338T DE69718338T2 DE 69718338 T2 DE69718338 T2 DE 69718338T2 DE 69718338 T DE69718338 T DE 69718338T DE 69718338 T DE69718338 T DE 69718338T DE 69718338 T2 DE69718338 T2 DE 69718338T2
Authority
DE
Germany
Prior art keywords
alkoxyisoxazole
substituted
acid derivatives
aminocarbonic acid
aminocarbonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69718338T
Other languages
English (en)
Other versions
DE69718338D1 (de
Inventor
Benny Bang-Andersen
Peter Bogeso
Povl Krogsgaard-Larsen
Lenz Sibylle Moltzen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Application granted granted Critical
Publication of DE69718338D1 publication Critical patent/DE69718338D1/de
Publication of DE69718338T2 publication Critical patent/DE69718338T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
DE69718338T 1996-10-04 1997-10-03 3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate Expired - Fee Related DE69718338T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK109296 1996-10-04
PCT/DK1997/000426 WO1998015542A1 (en) 1996-10-04 1997-10-03 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds

Publications (2)

Publication Number Publication Date
DE69718338D1 DE69718338D1 (de) 2003-02-13
DE69718338T2 true DE69718338T2 (de) 2003-10-16

Family

ID=8100908

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69718338T Expired - Fee Related DE69718338T2 (de) 1996-10-04 1997-10-03 3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate

Country Status (26)

Country Link
US (1) US6200999B1 (de)
EP (1) EP0934286B1 (de)
JP (1) JP2001501630A (de)
KR (1) KR20000048908A (de)
CN (1) CN1238766A (de)
AR (1) AR008880A1 (de)
AT (1) ATE230734T1 (de)
AU (1) AU733004B2 (de)
BG (1) BG103348A (de)
BR (1) BR9712198A (de)
CA (1) CA2268028C (de)
CZ (1) CZ116899A3 (de)
DE (1) DE69718338T2 (de)
EA (1) EA001625B1 (de)
ES (1) ES2189978T3 (de)
HU (1) HUP0000084A3 (de)
IL (1) IL129135A0 (de)
IS (1) IS5009A (de)
NO (1) NO312961B1 (de)
NZ (1) NZ334798A (de)
PL (1) PL332553A1 (de)
SK (1) SK42899A3 (de)
TR (1) TR199900724T2 (de)
UA (1) UA52698C2 (de)
WO (1) WO1998015542A1 (de)
ZA (1) ZA978877B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73749C2 (en) * 1999-11-01 2005-09-15 Diarylenines
IL154710A0 (en) 2000-09-15 2003-10-31 Vertex Pharma Isoxazole derivatives and pharmaceutical compositions containing the same
US20040106794A1 (en) * 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
UA78529C2 (en) 2001-10-10 2007-04-10 Wyeth Corp Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain
US20040152694A1 (en) * 2003-02-04 2004-08-05 Istvan Kurucz Methods and compositions for treating inflammatory disorders of the airways
PL1611144T3 (pl) 2003-04-09 2011-03-31 Wyeth Llc Pochodne kwasu 2-(8,9-diokso-2,6-diazabicyklo(5.2.0)non-1(7)-en-2-ylo)alkilofosfonowego i ich zastosowanie jako antagonistów receptora N-metylo-D-asparaginianu (NMDA)
TW200514775A (en) 2003-10-22 2005-05-01 Wyeth Corp Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof
KR101022082B1 (ko) * 2005-10-11 2011-03-17 에프. 호프만-라 로슈 아게 아이소옥사졸 유도체
WO2009092324A1 (en) * 2008-01-16 2009-07-30 Hong Kong University Of Science And Technology Oxazolidine derivatives as nmda antagonists
EP2338492A1 (de) 2009-12-24 2011-06-29 Universidad del Pais Vasco Verfahren und Zusammensetzung zur Behandlung von Alzheimer
TW201609719A (zh) 2014-05-28 2016-03-16 美國禮來大藥廠 作為ＴＡＲＰ－γ８依賴性ＡＭＰＡ受體拮抗劑之６－經取代－３Ｈ－１，３－苯并噻唑－２－酮化合物
WO2017126197A1 (ja) * 2016-01-21 2017-07-27 アグロカネショウ株式会社 ２－アミノニコチン酸ベンジルエステル誘導体の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2060303T3 (es) 1990-05-11 1994-11-16 Sankyo Co Derivados de piperidiloxiisoxazol y quinuclidiniloxiisoxazol, su preparacion y su uso terapeutico.
DE69325662T2 (de) 1992-10-23 2000-02-10 Merck Sharp & Dohme Dopamin rezeptor subtyp liganden
DK124393D0 (da) * 1993-11-03 1993-11-03 Lundbeck & Co As H Compounds

Also Published As

Publication number Publication date
PL332553A1 (en) 1999-09-13
EP0934286A1 (de) 1999-08-11
ES2189978T3 (es) 2003-07-16
NO991561D0 (no) 1999-03-30
AU4451797A (en) 1998-05-05
IS5009A (is) 1999-03-23
NZ334798A (en) 2000-06-23
AU733004B2 (en) 2001-05-03
NO312961B1 (no) 2002-07-22
ZA978877B (en) 1998-04-17
ATE230734T1 (de) 2003-01-15
CN1238766A (zh) 1999-12-15
SK42899A3 (en) 1999-08-06
WO1998015542A1 (en) 1998-04-16
HUP0000084A2 (hu) 2000-06-28
BG103348A (en) 1999-11-30
KR20000048908A (ko) 2000-07-25
UA52698C2 (uk) 2003-01-15
AR008880A1 (es) 2000-02-23
IL129135A0 (en) 2000-02-17
TR199900724T2 (xx) 1999-06-21
DE69718338D1 (de) 2003-02-13
CA2268028C (en) 2003-03-18
HUP0000084A3 (en) 2001-12-28
CA2268028A1 (en) 1998-04-16
US6200999B1 (en) 2001-03-13
BR9712198A (pt) 1999-08-31
EP0934286B1 (de) 2003-01-08
CZ116899A3 (cs) 1999-09-15
JP2001501630A (ja) 2001-02-06
EA199900358A1 (ru) 1999-10-28
NO991561L (no) 1999-06-04
EA001625B1 (ru) 2001-06-25

Similar Documents

Publication Publication Date Title
DE69703385D1 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
DE69735712D1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
PT925298E (pt) Derivados 6,6-hetero-biciclicos substituidos
ATE260243T1 (de) N-aroylphenylalaninderivate
ATE235220T1 (de) Resorcinderivate
DE69817186D1 (de) Diaminorhodamin-derivate
NO981946D0 (no) Imidazoquinazolin-derivater
IS4800A (is) Nýjar 19-nor-pregnene afleiður
TR199802289A3 (tr) Fosfonasit-ikame etmis benzazepinon-n-asetikasit türevleri.
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
ATE255098T1 (de) Substituierte chromanderivate
IS5562A (is) Nýjar díhýdroxýhexanósýru afleiður
ATE255099T1 (de) Substituierte chromanderivate
ATE440854T1 (de) 5-deoxy-cytidin-derivate
ATE230734T1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
DE59707658D1 (de) Glyoxylsäure-derivate
ATE292632T1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
DE69713354D1 (de) Hydroxamsäure-derivate
EE04061B1 (et) Metüleenbisfosfoonhappe derivaadid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee